| 000 | 01740 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250517054122.0 | ||
| 264 | 0 | _c20151224 | |
| 008 | 201512s 0 0 eng d | ||
| 022 | _a1478-7083 | ||
| 024 | 7 |
_a10.1308/rcsann.2015.0011 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLightbody, K A | |
| 245 | 0 | 0 |
_aInjection of botulinum toxin for the treatment of post-laryngectomy pharyngoesophageal spasm-related disorders. _h[electronic resource] |
| 260 |
_bAnnals of the Royal College of Surgeons of England _cOct 2015 |
||
| 300 |
_a508-12 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aBotulinum Toxins, Type A _xtherapeutic use |
| 650 | 0 | 4 |
_aDysphonia _xdrug therapy |
| 650 | 0 | 4 |
_aEsophageal Diseases _xdrug therapy |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInjections, Intramuscular |
| 650 | 0 | 4 | _aLaryngectomy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNeuromuscular Agents _xtherapeutic use |
| 650 | 0 | 4 | _aPatient Satisfaction |
| 650 | 0 | 4 |
_aPharyngeal Diseases _xdrug therapy |
| 650 | 0 | 4 |
_aPostoperative Complications _xdrug therapy |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 | _aQuality of Life |
| 650 | 0 | 4 |
_aSpasm _xdrug therapy |
| 650 | 0 | 4 | _aSurveys and Questionnaires |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aWilkie, M D | |
| 700 | 1 | _aKinshuck, A J | |
| 700 | 1 | _aGilmartin, E | |
| 700 | 1 | _aLewis-Jones, H | |
| 700 | 1 | _aJones, T M | |
| 700 | 1 | _aLancaster, J | |
| 773 | 0 |
_tAnnals of the Royal College of Surgeons of England _gvol. 97 _gno. 7 _gp. 508-12 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1308/rcsann.2015.0011 _zAvailable from publisher's website |
| 999 |
_c25303469 _d25303469 |
||